OMDA logo

Omada Health, Inc. Stock Price

NasdaqGS:OMDA Community·US$1.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

OMDA Share Price Performance

US$20.18
2.85 (16.45%)
US$24.58
Fair Value
US$20.18
2.85 (16.45%)
17.9% undervalued intrinsic discount
US$24.58
Fair Value
Price US$20.18
AnalystConsensusTarget US$24.58
AnalystHighTarget US$30.00
AnalystLowTarget US$15.00

OMDA Community Narratives

·
Fair Value US$24.58 17.9% undervalued intrinsic discount

GLP-1 Expansion And AI Integration Will Drive Long-Term Chronic Care Leadership

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
·
Fair Value US$30 32.7% undervalued intrinsic discount

GLP-1 And AI Care Platform Will Support Powerful Long Term Chronic Condition Tailwinds

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$15 34.5% overvalued intrinsic discount

GLP-1 Complexity And Rising Costs Will Challenge Virtual Care Scale Yet Eventually Support Returns

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

OMDA logo

OMDA: Index Reclassification And Eli Lilly Partnership Will Drive Future Upside

Fair Value: US$24.58 17.9% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
OMDA logo

OMDA: GLP-1 Care Partnership Will Drive Future Earnings Re-Rating

Fair Value: US$30 32.7% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
OMDA logo

OMDA: GLP-1 Program Reliance Will Drive Lower Future Return Expectations

Fair Value: US$15 34.5% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
3 Rewards

Omada Health, Inc. Key Details

US$283.3m

Revenue

US$95.6m

Cost of Revenue

US$187.7m

Gross Profit

US$194.0m

Other Expenses

-US$6.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
-0.11
66.27%
-2.22%
0%
View Full Analysis

About OMDA

Founded
2011
Employees
943
CEO
Sean Duffy
WebsiteView website
www.omadahealth.com

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Recent OMDA News & Updates

Narrative Update Jul 24

OMDA: Index Reclassification And Eli Lilly Partnership Will Drive Future Upside

Analysts now place Omada Health's fair value at $24.58 per share, compared with the prior $28.90. They cite updated views on revenue growth, profit margins, the discount rate, and future P/E assumptions.

Recent updates

No updates